Latest Ratings for LMND Date Firm Action From To Mar 2022 Morgan Stanley Maintains Equal-Weight Feb 2022 Oppenheimer Maintains Outperform Feb 2022 Piper Sandler Maintains Overweight View More Analyst Ratings for LMND View the Latest Analyst Ratings read more